Survival analysis revealed that TMEM150A overexpression was associated with poor OS and DSS in male and female patients, regardless of their race, age ≤60, KPS≥80, or IDH wild-type (WT) status in patients with GBM (Figs 3 and 4). The gene discussed is TMEM150A; the disease is glioblastoma.